Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692860012 | Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3692861011 | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Is a | Product containing betamethasone and fusidic acid (medicinal product) | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has active ingredient | Betamethasone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has active ingredient | Fusidic acid (substance) | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Is a | Product containing fusidic acid in topical dosage form | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has precise active ingredient | Fusidic acid (substance) | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has precise active ingredient | Betamethasone valerate (substance) | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has basis of strength substance (attribute) | Fusidic acid (substance) | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has basis of strength substance (attribute) | Betamethasone | true | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Is a | Product containing betamethasone valerate in topical dosage form | false | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength numerator value | 1 | false | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Is a | Betamethasone and fusidic acid only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR